5 (of Many) Growth Companies to Buy - TheStreet

5 (of Many) Growth Companies to Buy

Investors shouldn't abandon hope, managers say, just look a little harder for good-value companies.
Author:
Publish date:

Even in this slow-moving economy, there is growth out there. You just have to find it, says a slew of top growth fund managers.

The

iShares S&P 500 Growth Index ETF

(IVW) - Get Report

has returned barely a half-percent year-to-date compared with the

iShares S&P 500 Value Index ETF

(IVE) - Get Report

, which is up 2.3% since January. The fact that value is trumping growth should be no surprise, considering America's GDP has declined as the year has progressed, from 3.7% in the first quarter to 1.6% in the second, and expectations for the rest of the year are not high.

Still, growth fund managers say their investors should not abandon hope and throw in their lots with the value crowd. There are companies growing their top lines and trading at deservedly rich multiples -- meaning they're worth buying. Here are a few of the managers' favorites:

GOOGLE

(GOOG) - Get Report

"The advance of connected devices throughout the world is the most significant secular growth trend in the world right now, and Google is the best-positioned company to participate in the ride."

-- Keith Goddard, co-manager of the Capital Advisors Growth Fund

(CIAOX) - Get Report

WYNN RESORTS

(WYNN) - Get Report

-- "Wynn continues to look very attractive over the long-term, given the likelihood of a continued recovery in the United States and its exposure to China through its significant presence in Macau."

-- Michael Cuggino, portfolio manager of the Permanent Portfolio Aggressive Growth fund

(PAGRX) - Get Report

.

COGNIZANT TECHNOLOGY SOLUTIONS

(CTSH) - Get Report

"In tough times, companies can stretch their dollars by outsourcing information technology projects that enhance cost containment while improving business processes with minimal investment, and we believe Cognizant is one of the best at doing this in this fast-growing industry."

-- Kevin Walkush, Business Analyst for the Jensen Fund

(JENSX) - Get Report

.

CEPHALON

(CEPH)

"It's an exciting biotech stock trading at less than nine times estimated earnings for this year, and it's growing earnings this year over 20%, yet the stock is down year to date slightly."

-- Bob Auer, portfolio manager of the Auer Growth Fund

(AUERX) - Get Report

TRANSOCEAN

(RIG) - Get Report

"A year from now people will not be talking about the Gulf Oil spill, and Transocean should be back to where it was before the spill -- around $95 for a 35% to 40% return."

-- Craig Hodges, co-manager of the Hodges Fund

(HDPMX) - Get Report

>To submit a news tip, email:

tips@thestreet.com

.

RELATED STORIES:

>>Bye-Bye Back-to-School, Hello Christmas

>>Reasons to Fear the Fall

>>Jones Villalta Loves the Loathed of Wall Street

Follow TheStreet.com on

Twitter

and become a fan on

Facebook.

Disclosure: TheStreet's editorial policy prohibits staff editors and reporters from holding positions in any individual stocks.